Results 241 to 250 of about 101,340 (329)
Alcohol, Clinical and Experimental Research, EarlyView.This study shows that chronic alcohol exposure leads to sex‐specific disruptions in local field potentials, specifically causing changes to amygdala oscillations in females and prefrontal cortical and nucleus accumbens oscillations in males. These data may explain some of the sex differences observed in alcohol misuse and provide potential biomarkers ...
Kelly A. Hewitt +4 more
wiley +1 more source
Feedback inhibition of dopamine synthesis by continuous administration of dopamine agonists
, 2000 Shin-ichi Iwata +3 more
openalex +1 more source
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Introduction Bipolar disorder (BD), characterized by extreme mood shifts between mania and depression, can manifest in childhood, and pose treatment challenges. Treatment for full‐criteria BD I or II in children has been partially described in the literature, but major uncertainties exist regarding non‐classic presentations, which were ...
Demitri F. Papolos +2 more
wiley +1 more source
Impulse control and related behavioral disorders (ICRD) in Idiopathic Parkinson's Disease treated with different dopamine agonists in Hong Kong: Is any dopamine agonist better? [PDF]
Clin Park Relat DisordWu HF +10 more
europepmc +1 more source
Dihydrexidine — The First Full Dopamine D1 Receptor Agonist [PDF]
, 2004 Peter Salmi, Ruben Isacson, Björn Kull
openalex +1 more source
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review
Addiction, EarlyView.Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper +7 more
wiley +1 more source
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Xylazine, an alpha‐2‐adrenergic agonist, has been increasingly implicated in substance use and overdose crises. However, little is known about its effects on humans. With the growing public health crisis surrounding xylazine, it has become important to recognize and promptly manage symptoms of xylazine toxicity ...
Philipa Owusu‐Antwi +4 more
wiley +1 more source
The American Journal on Addictions, EarlyView.Abstract Background Opioid use disorder (OUD) imposes a significant socioeconomic burden, highlighting the need for new interventions. Objective This study investigated whether exposure to 5‐alpha reductase inhibitors (5αRIs) is associated with a lower risk of developing OUD.
Abdelrahman G. Tawfik +5 more
wiley +1 more source
Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis. [PDF]
Eur J Clin Pharmacol, 2020 Binde CD +4 more
europepmc +1 more source